Trial Outcomes & Findings for Developing and Assessing a Male Engagement Intervention in Option B+ in Malawi (NCT NCT03477279)
NCT ID: NCT03477279
Last Updated: 2021-06-24
Results Overview
HIV-positive male partners who presented at 12 months with a viral load \<1000 copies/mL
COMPLETED
NA
1116 participants
12 months
2021-06-24
Participant Flow
Participant milestones
| Measure |
Individual (HIV+ Women)
HIV-infected pregnant women enrolled in the individual arm of the study will receive Standard of Care Option B+ procedures.
|
Couple (HIV+ Women)
These women will receive 1) support to recruit their male partners, 2) enhanced couple counseling and testing, and 3) support for male partner engagement in care.
|
Male Partners of Women in Individual
These men will have access to standard of care procedures.
|
Male Partners of Women in Couple
These men will receive 1) support with recruitment, 2) enhanced couple counseling and testing, and 3) support for engagement in care.
|
Control Population (HIV- Women)
HIV-negative pregnant women will be invited to participate in a cross-sectional study. No intervention will be provided and no follow-up will be conducted.
|
|---|---|---|---|---|---|
|
Overall Study
STARTED
|
250
|
250
|
98
|
168
|
350
|
|
Overall Study
COMPLETED
|
203
|
202
|
98
|
136
|
349
|
|
Overall Study
NOT COMPLETED
|
47
|
48
|
0
|
32
|
1
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
Individual (HIV+ Women)
n=246 Participants
HIV-positive pregnant women enrolled in the Individual arm will receive Standard of Care Option B+ procedures.
|
Couple (HIV+ Women)
n=249 Participants
HIV-positive pregnant women enrolled in the Couple arm will receive 1) support to recruit their male partners, 2) enhanced couple counseling and testing, and 3) support for male partner engagement in care.
|
Male Partners of Women in Individual
n=98 Participants
These men will have access to standard of care procedures.
|
Male Partners of Women in Couple
n=167 Participants
These men will receive 1) support with recruitment, 2) enhanced couple counseling and testing, and 3) support for engagement in care.
|
Control Population (HIV- Women)
n=349 Participants
HIV-negative pregnant women will be invited to participate in a cross-sectional study. No intervention will be provided and no follow-up will be conducted.
|
Total
n=1109 Participants
Total of all reporting groups
|
|---|---|---|---|---|---|---|
|
Age, Categorical
<=18 years
|
15 Participants
n=246 Participants
|
11 Participants
n=249 Participants
|
1 Participants
n=98 Participants
|
0 Participants
n=167 Participants
|
37 Participants
n=349 Participants
|
64 Participants
n=1109 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
231 Participants
n=246 Participants
|
238 Participants
n=249 Participants
|
97 Participants
n=98 Participants
|
167 Participants
n=167 Participants
|
312 Participants
n=349 Participants
|
1045 Participants
n=1109 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=246 Participants
|
0 Participants
n=249 Participants
|
0 Participants
n=98 Participants
|
0 Participants
n=167 Participants
|
0 Participants
n=349 Participants
|
0 Participants
n=1109 Participants
|
|
Sex: Female, Male
Female
|
246 Participants
n=246 Participants
|
249 Participants
n=249 Participants
|
0 Participants
n=98 Participants
|
0 Participants
n=167 Participants
|
349 Participants
n=349 Participants
|
844 Participants
n=1109 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=246 Participants
|
0 Participants
n=249 Participants
|
98 Participants
n=98 Participants
|
167 Participants
n=167 Participants
|
0 Participants
n=349 Participants
|
265 Participants
n=1109 Participants
|
|
Race and Ethnicity Not Collected
|
—
|
—
|
—
|
—
|
—
|
0 Participants
Race and Ethnicity were not collected from any participant.
|
|
Region of Enrollment
Malawi
|
246 Participants
n=246 Participants
|
249 Participants
n=249 Participants
|
98 Participants
n=98 Participants
|
167 Participants
n=167 Participants
|
349 Participants
n=349 Participants
|
1109 Participants
n=1109 Participants
|
PRIMARY outcome
Timeframe: 12 monthsPopulation: This is an HIV-positive female only outcome. 134 HIV-positive women did not present for the 12 month study visit
Women who presented at 12 months and reported taking at least one dose of ART in the last seven days
Outcome measures
| Measure |
Individual (HIV+ Women)
n=181 Participants
HIV-positive pregnant women enrolled in the Individual arm will receive Standard of Care Option B+ procedures.
|
Couple (HIV+ Women)
n=185 Participants
HIV-positive pregnant women enrolled in the Couple arm will receive 1) support to recruit their male partners, 2) enhanced couple counseling and testing, and 3) support for male partner engagement in care.
|
|---|---|---|
|
Number of Women Retained in Care
|
160 Participants
|
164 Participants
|
PRIMARY outcome
Timeframe: 12 monthsPopulation: This is an HIV-positive female only outcome.138 HIV-positive women did not present for the 12 month study visit or did not provide the blood sample required for viral load ascertainment
Women who presented at 12 months with a viral load \<1000 copies/mL
Outcome measures
| Measure |
Individual (HIV+ Women)
n=178 Participants
HIV-positive pregnant women enrolled in the Individual arm will receive Standard of Care Option B+ procedures.
|
Couple (HIV+ Women)
n=184 Participants
HIV-positive pregnant women enrolled in the Couple arm will receive 1) support to recruit their male partners, 2) enhanced couple counseling and testing, and 3) support for male partner engagement in care.
|
|---|---|---|
|
Number of Women With Viral Suppression
|
145 Participants
|
162 Participants
|
PRIMARY outcome
Timeframe: 12 monthsPopulation: This is a male only outcome. 141 men did not present at 12 months, or refused HIV testing at 12 months, or tested HIV-negative/indeterminate at 12 months
HIV-positive male partners who presented at 12 months and reported knowing they were HIV-positive prior to receiving the results of the HIV test conducted at the 12 month study visit
Outcome measures
| Measure |
Individual (HIV+ Women)
n=53 Participants
HIV-positive pregnant women enrolled in the Individual arm will receive Standard of Care Option B+ procedures.
|
Couple (HIV+ Women)
n=72 Participants
HIV-positive pregnant women enrolled in the Couple arm will receive 1) support to recruit their male partners, 2) enhanced couple counseling and testing, and 3) support for male partner engagement in care.
|
|---|---|---|
|
Number of HIV-positive Male Partners Aware of Their HIV-positive Status
|
44 Participants
|
67 Participants
|
PRIMARY outcome
Timeframe: 12 monthsPopulation: This is a male only outcome. 142 men did not present at 12 months, or refused HIV testing at 12 months, or tested HIV-negative/indeterminate at 12 months, or did not report information on ART use
HIV-positive male partners who presented at 12 months and reported taking at least one dose of ART in the last seven days
Outcome measures
| Measure |
Individual (HIV+ Women)
n=52 Participants
HIV-positive pregnant women enrolled in the Individual arm will receive Standard of Care Option B+ procedures.
|
Couple (HIV+ Women)
n=72 Participants
HIV-positive pregnant women enrolled in the Couple arm will receive 1) support to recruit their male partners, 2) enhanced couple counseling and testing, and 3) support for male partner engagement in care.
|
|---|---|---|
|
Number of HIV-positive Male Partners Retained in Care
|
34 Participants
|
59 Participants
|
PRIMARY outcome
Timeframe: 12 monthsPopulation: This is a male only outcome. 141 men did not present at 12 months, or refused HIV testing at 12 months, or tested HIV-negative/indeterminate at 12 months, or did not provide the blood sample required for viral load ascertainment
HIV-positive male partners who presented at 12 months with a viral load \<1000 copies/mL
Outcome measures
| Measure |
Individual (HIV+ Women)
n=53 Participants
HIV-positive pregnant women enrolled in the Individual arm will receive Standard of Care Option B+ procedures.
|
Couple (HIV+ Women)
n=72 Participants
HIV-positive pregnant women enrolled in the Couple arm will receive 1) support to recruit their male partners, 2) enhanced couple counseling and testing, and 3) support for male partner engagement in care.
|
|---|---|---|
|
Number of HIV-positive Male Partners With Viral Suppression
|
31 Participants
|
53 Participants
|
PRIMARY outcome
Timeframe: 12 monthsPopulation: This is a male only outcome. 162 did not present at 12 months, or refused HIV testing at 12 months, or tested HIV-positive/indeterminate at 12 months
HIV-negative men with a) consistent condom use in the last six months or b) a suppressed female partner or c) abstinence with primary partner
Outcome measures
| Measure |
Individual (HIV+ Women)
n=41 Participants
HIV-positive pregnant women enrolled in the Individual arm will receive Standard of Care Option B+ procedures.
|
Couple (HIV+ Women)
n=63 Participants
HIV-positive pregnant women enrolled in the Couple arm will receive 1) support to recruit their male partners, 2) enhanced couple counseling and testing, and 3) support for male partner engagement in care.
|
|---|---|---|
|
Number of HIV-negative Men Without HIV Exposure From Their Primary Partner
|
39 Participants
|
59 Participants
|
SECONDARY outcome
Timeframe: 12 monthsPopulation: This is an HIV-positive female only outcome. For 154 observations, there was no data available on infant outcomes or no live birth
HIV-positive female participants who reported a live birth and uptake of early infant diagnosis
Outcome measures
| Measure |
Individual (HIV+ Women)
n=171 Participants
HIV-positive pregnant women enrolled in the Individual arm will receive Standard of Care Option B+ procedures.
|
Couple (HIV+ Women)
n=175 Participants
HIV-positive pregnant women enrolled in the Couple arm will receive 1) support to recruit their male partners, 2) enhanced couple counseling and testing, and 3) support for male partner engagement in care.
|
|---|---|---|
|
Number of HIV-positive Female Participants Who Reported Early Infant Diagnosis
|
162 Participants
|
158 Participants
|
SECONDARY outcome
Timeframe: At the day of female consentPopulation: This is a female only outcome. Of the 500 HIV-positive women enrolled into the study, 44 were classified as having recently acquired HIV. Data unavailable for one HIV-negative woman.
Risk factor analysis to identify predictors of recent HIV infection among pregnant women
Outcome measures
| Measure |
Individual (HIV+ Women)
n=44 Participants
HIV-positive pregnant women enrolled in the Individual arm will receive Standard of Care Option B+ procedures.
|
Couple (HIV+ Women)
n=349 Participants
HIV-positive pregnant women enrolled in the Couple arm will receive 1) support to recruit their male partners, 2) enhanced couple counseling and testing, and 3) support for male partner engagement in care.
|
|---|---|---|
|
Predictors of Recent HIV Infection
Married to Primary Partner
|
38 Participants
|
338 Participants
|
|
Predictors of Recent HIV Infection
Not Married to Primary Partner
|
6 Participants
|
11 Participants
|
Adverse Events
Individual (HIV+ Women)
Couple (HIV+ Women)
Male Partners of Women in Individual
Male Partners of Women in Couple
Control Population (HIV- Women)
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Nora Rosenberg, PhD, MSPH
University of North Carolina at Chapel Hill
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place